Strategies for the augmentation of grafted dopamine neuron survival.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Frontiers in Bioscience

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/1096PMID 12700087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats

  2004cited by this paper
• Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier

  2004cited by this paper
• Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.

  2003cited by this paper
• Interference with anoikis‐induced cell death of dopamine neurons: Implications for augmenting embryonic graft survival in a rat model of Parkinson's disease

  2003cited by this paper
• Recent advances in the genetics and pathogenesis of Parkinson disease

  2002cited by this paper
• Caspases on the brain

  2002cited by this paper
• Enhanced Vascularization and Survival of Neural Transplants with Ex Vivo Angiogenic Gene Transfer

  2002cited by this paper
• Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons.

  2002cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Growth and Functional Efficacy of Intrastriatal Nigral Transplants Depend on the Extent of Nigrostriatal Degeneration

  2001cited by this paper
• Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum.

  2001cited by this paper
• Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail.

  2001cited by this paper
• Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.

  2001cited by this paper
• Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.

  2001cited by this paper
• Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.

  2000cited by this paper
• Fetal Neuron Grafts Pave the Way for Stem Cell Therapies

  2000cited by this paper
• Oligodendrocyte‐type 2 astrocyte‐derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death

  2000cited by this paper
• Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons.

  2000cited by this paper
• Vascular endothelial growth factor and the regulation of angiogenesis.

  2000cited by this paper
• Increased survival of embryonic nigral neurons when grafted to hypothermic rats

  2000cited by this paper
• Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.

  2000cited by this paper
• Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons

  1999cited by this paper
• Apoptosis in neuronal development and transplantation: role of caspases and trophic factors.

  1999cited by this paper
• Caspase inhibition reduces apoptosis and increases survival of nigral transplants

  1999cited by this paper
• Therapeutic Potential of Nerve Growth Factors in Parkinson’s Disease

  1999cited by this paper
• Neurturin enhances the survival of intrastriatal fetal dopaminergic transplants.

  1999cited by this paper
• New prospects for human stem-cell therapy in the nervous system.

  1999cited by this paper
• Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery.

  1999cited by this paper
• Caspases in Developmental Cell Death

  1999cited by this paper
• GDNF Protection against 6-OHDA–Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine

  1999cited by this paper
• Differential effects of Bcl‐2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants

  1999cited by this paper
• Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

  1999cited by this paper
• Diminished Viability, Growth, and Behavioral Efficacy of Fetal Dopamine Neuron Grafts in Aging Rats with Long-Term Dopamine Depletion: An Argument for Neurotrophic Supplementation

  1999cited by this paper
• Flunarizine improves the survival of grafted dopaminergic neurons.

  1999cited by this paper
• Co‐grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons

  1998cited by this paper
• Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia

  1998cited by this paper
• Prolonged Therapeutic Window for Ischemic Brain Damage Caused by Delayed Caspase Activation

  1998cited by this paper
• Glial Cell Line-Derived Neurotrophic Factor Improves Survival of Dopaminergic Neurons in Transplants of Fetal Ventral Mesencephalic Tissue

  1998cited by this paper
• Growth/differentiation factor 5 and glial cell line‐derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease

  1998cited by this paper
• Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.

  1998cited by this paper
• MK‐801 does not enhance dopaminergic cell survival in embryonic nigral grafts

  1998cited by this paper
• Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.

  1998cited by this paper
• Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia

  1998cited by this paper
• Integrins and anoikis.

  1997cited by this paper
• Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Early Developmental Destruction of Terminals in the Striatal Target Induces Apoptosis in Dopamine Neurons of the Substantia Nigra

  1997cited by this paper
• The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra.

  1997cited by this paper
• Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants.

  1997cited by this paper
• Caspases and caspase inhibitors.

  1997cited by this paper
• Bcl-2 promotes regeneration of severed axons in mammalian CNS

  1997cited by this paper
• Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.

  1997cited by this paper
• Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

  1997cited by this paper
• Interaction and Regulation of Subcellular Localization of CED-4 by CED-9

  1997cited by this paper
• The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation.

  1996cited by this paper
• Fetal nigral transplantation as a therapy for Parkinson's disease.

  1996cited by this paper
• Is levodopa toxic?

  1996cited by this paper
• Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.

  1996cited by this paper
• Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

  1996cited by this paper
• Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development.

  1996cited by this paper
• Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity.

  1996cited by this paper
• A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult.

  1996cited by this paper
• Very Delayed Infarction after Mild Focal Cerebral Ischemia: A Role for Apoptosis?

  1996cited by this paper
• Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo

  1996cited by this paper
• The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.

  1996cited by this paper
• Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

  1995cited by this paper
• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  1995cited by this paper
• Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease

  1995cited by this paper
• Embryo research tests NIH's mettle

  1995cited by this paper
• Neural apoptosis

  1995cited by this paper
• Neural transplantation of cells expressing the anti-apoptotic gene bcl-2.

  1995cited by this paper
• Mechanisms and genes of cellular suicide

  1995cited by this paper
• Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family.

  1995cited by this paper
• Lazaroids improve the survival of grafted rat embryonic dopamine neurons.

  1994cited by this paper
• Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture.

  1994cited by this paper
• Apoptosis in substantia nigra following developmental striatal excitotoxic injury.

  1994cited by this paper
• bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS.

  1994cited by this paper
• Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation

  1994cited by this paper
• Programmed cell death in developing grafts of fetal substantia nigra.

  1994cited by this paper
• bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain.

  1994cited by this paper
• Oligodendrocyte-type-2 astrocyte (O-2A) progenitors increase the survival of rat mesencephalic, dopaminergic neurons from death induced by serum deprivation.

  1994cited by this paper
• Oxidative stress as a mediator of apoptosis.

  1994cited by this paper
• Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.

  1994cited by this paper
• Naturally Occurring Cell Death during Postnatal Development of the Substantia Nigra Pars Compacta of Rat.

  1993cited by this paper
• Programmed cell death and the control of cell survival: lessons from the nervous system.

  1993cited by this paper
• Bcl-2 gene is highly expressed during neurogenesis in the central nervous system.

  1993cited by this paper
• Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro.

  1993cited by this paper
• Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin‐1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation

  1993cited by this paper
• The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis.

  1993cited by this paper
• N‐Acetylcysteine inhibits apoptosis and decreases viral particles in HIV‐chronically infected U937 cells

  1993cited by this paper
• Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor

  1993cited by this paper
• Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons.

  1993cited by this paper
• Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene.

  1992cited by this paper
• Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

  1992cited by this paper
• Innovative treatment or ethical headache? Fetal transplantation in Parkinson's disease.

  1992cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts.

  1991cited by this paper
• Vascular permeability factor: A unique regulator of blood vessel function

  1991cited by this paper

• Understanding the Influence of Target Acquisition on Survival, Integration, and Phenotypic Maturation of Dopamine Neurons within Stem Cell-Derived Neural Grafts in a Parkinson's Disease Model

  2022cites this paper
• Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson’s disease model

  2022cites this paper
• Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson’s Disease Model

  2022cites this paper
• A stimuli-responsive, pentapeptide, nanofiber hydrogel for tissue engineering

  2019influential citation
• Cell Transplantation in PD 31 31 2 Developing Novel Cell Sources for Transplantation in Parkinson ’ s Disease

  2018cites this paper
• The effect of L-dopa and neuroprotective agents on cell replacement therapy for Parkinson's disease

  2017cites this paper
• Mesenchymal Stem Cells and the Prospect of its Application in the Treatment of stroke

  2016cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2016cites this paper
• Review: The fate of cell grafts for the treatment of Huntington's disease: the post‐mortem evidence

  2014cites this paper
• Cell replacement therapy for Huntington's disease : what we have learned from post-mortem analyses of grafted patients and mice models

  2014cites this paper
• A multi-modality platform to image stem cell graft survival in the naïve and stroke-damaged mouse brain.

  2014cites this paper
• Single-Cell Suspension Methodology Favors Survival and Vascularization of Fetal Striatal Grafts in the YAC128 Mouse Model of Huntington's Disease

  2014cites this paper
• Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.

  2014influential citation
• Ion Channels in Regulation of Neuronal Regenerative Activities

  2014cites this paper
• Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats.

  2014cites this paper
• Pitfalls and fallacies interfering with correct identification of embryonic stem cells implanted into the brain after experimental traumatic injury.

  2013cites this paper
• Epigenetic mechanisms in the development and maintenance of dopaminergic neurons

  2013cites this paper
• Intranasal Delivery of Neural Stem/Progenitor Cells: A Noninvasive Passage to Target Intracerebral Glioma

  2012cites this paper
• Selenite benefits embryonic stem cells therapy in Parkinson's disease.

  2012cites this paper
• Building stem cell niches from the molecule up through engineered peptide materials.

  2012cites this paper
• Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation.

  2012influential citation
• Motoneuron Replacement for Reinnervation of Skeletal Muscle in Adult Rats

  2012cites this paper
• Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease

  2012cites this paper
• Multitract Microtransplantation Increases the Yield of DARPP-32-Positive Embryonic Striatal Cells in a Rodent Model of Huntington's Disease

  2011cites this paper
• Improving Viability of Stem Cells During Syringe Needle Flow Through the Design of Hydrogel Cell Carriers

  2011cites this paper
• A Calpain Inhibitor Enhances the Survival of Schwann Cells In Vitro and after Transplantation into the Injured Spinal Cord

  2010influential citation
• A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells.

  2010cites this paper
• Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo

  2010cites this paper
• Neurotrophic factors improve muscle reinnervation from embryonic neurons

  2010cites this paper
• Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters

  2009cites this paper
• Neurotrophic Factors Improve Motoneuron Survival and Function of Muscle Reinnervated by Embryonic Neurons

  2009cites this paper
• Cell therapy in brain neurodegenerative movement disorders :a clinical perspective

  2009cites this paper
• Stem cells for ischemic brain injury: A critical review

  2009cites this paper
• Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: Current state and problems

  2009cites this paper
• 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

  2008cites this paper
• Growth Factors and Feeder Cells Promote Differentiation of Human Embryonic Stem Cells into Dopaminergic Neurons: A Novel Role for Fibroblast Growth Factor-20

  2008influential citation
• Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.

  2008cites this paper
• Stem cell‐based cellular replacement strategies following traumatic brain injury (TBI)

  2008cites this paper
• Emerging restorative treatments for Parkinson's disease.

  2008cites this paper
• Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

  2007cites this paper
• How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson’s disease?

  2007cites this paper
• How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson’s disease?

  2007cites this paper
• Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord

  2007cites this paper
• Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

  2007cites this paper
• Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.

  2007cites this paper
• Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro.

  2007cites this paper
• Molecular imaging of cell transplantation in Parkinson’s disease

  2006cites this paper
• Transplantation of Cryopreserved Human Bone Marrowderived Multipotent Adult Progenitor Cells for Neonatal Hypoxie- Ischemic Injury: Targeting the Hippocampus

  2006cites this paper
• Fetal hippocampal CA3 cell grafts enriched with FGF-2 and BDNF exhibit robust long-term survival and integration and suppress aberrant mossy fiber sprouting in the injured middle-aged hippocampus.

  2006cites this paper
• Molecular imaging of cell transplantation in Parkinson’s disease

  2006cites this paper
• Important Aspects of Surgical Methodology for Transplantation in Parkinson's Disease

  2006cites this paper
• Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

  2006cites this paper
• Developing Novel Cell Sources for Transplantation in Parkinson’s Disease

  2006cites this paper
• Incorporation of embryonic CA3 cell grafts into the adult hippocampus at 4-months after injury: effects of combined neurotrophic supplementation and caspase inhibition.

  2006cites this paper
• Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons

  2006cites this paper
• Behavioral and Histological Characterization of Intrahippocampal Grafts of Human Bone Marrow-Derived Multipotent Progenitor Cells in Neonatal Rats with Hypoxic-Ischemic Injury

  2006cites this paper
• Stem cell transplantation as a therapeutic strategy for traumatic brain injury.

  2005cites this paper
• Caspase-mediated cell death predominates following engraftment of neural progenitor cells into traumatically injured rat brain.

  2005cites this paper
• Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.

  2005cites this paper
• Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient

  2005cites this paper
• Dopamine D3 receptor‐preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons

  2005cites this paper
• Stem cells may reshape the prospect of Parkinson's disease therapy.

  2005cites this paper
• Reassessment of Caspase Inhibition to Augment Grafted Dopamine Neuron Survival

  2004cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue : a role for protease activation

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation

  2003cites this paper
• Interference with anoikis‐induced cell death of dopamine neurons: Implications for augmenting embryonic graft survival in a rat model of Parkinson's disease

  2003cites this paper
• Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.

  2003cites this paper
• P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

  year unknowncites this paper